..., Mass., May 14 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced that the results from its Phase II coronary revascularization trial have been .... The paper is entitled "Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design, and haemodynamic results." The manuscript was ...
RE: ARTICLE FEEDBACK: Biopure Announces Publication of Phase IIProof-of-Concept Coronary Trial
2 months, 1 week ago (2008-05-14 17:33:00)
by arctickat
Source:
EMS Village Forums
Forum:
Research Center
Thread:
Show this thread (2 posts)
Size: 1,121 bytes
Links: emsvillage.com profile
Customize:
EMS Village Forums
Forum:
Research Center
Thread:
Show this thread (2 posts)
Size: 1,121 bytes
Links: emsvillage.com profile
Customize:
